How to read these. Each engagement below is described at the level our confidentiality terms allow. Where a figure is shown, it is the outcome the client reported. Where it says confidential, the outcome exists but we are not free to publish it. We can often speak to it under NDA.
Biotechnology
M&A due diligence and investment
Performed M&A due diligence of a startup company for an investment group with IP, R&D and commercial readiness assessments. Advised the client on the investment required and helped structure the final deal.
- Result
- $24M invested
What that involved
- Led M&A due diligence for a startup target
- Assessed intellectual property, covering ownership, patents, licensing and freedom to operate
- Evaluated R&D and commercial readiness
- Required capital analysis, valuation and final transaction structure
Life sciences & biotech
CDMO startup and fundraise
Oversaw the entire setup from company registration through seed investment and manufacturing site setup, for a company that did not exist when the engagement began.
- Result
- $3M raised
What that involved
- Company registration and corporate structuring from zero
- Investor materials and the seed process through to close
- Manufacturing site selection and setup
- Operating leadership across all three in parallel
Fortune 200 client
New product commercialization
Start-to-finish product roadmap with a clear immediate commercialization route and a long-term local development strategy, including the launch of the first product.
- Result
- $30M+ / 3 yrs
What that involved
- Product roadmap built against a defined commercialization route
- Long-term local development strategy alongside the near-term launch
- First product taken to market
- Revenue compounding to more than $30M over three years
US market expansion
Product expansion into the USA
Established and executed a joint commercial program between the client and a Fortune 50 company, and developed the MVP used for pilot testing.
- Result
- Confidential
What that involved
- Structuring a joint commercial program with a Fortune 50 partner
- Negotiating and executing it on the client's behalf
- MVP development for the pilot
- Running the pilot through to evaluation
Technology
Scaling a technology brand
Directed national expansion and operational strategy for a flexible living and property technology company, scaling the portfolio and revenue base in a volatile regulatory environment.
- Result
- Confidential
What that involved
- National expansion strategy and its execution
- Portfolio and revenue base scaled through the expansion
- Business model adapted to comply with new market rules mid-flight
- Profitability and service quality held through the change